share_log

Acer Therapeutics Q4 EPS $(0.54) Misses $(0.37) Estimate

Benzinga ·  Mar 27, 2023 16:03

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.37) by 45.95 percent. This is a 74.19 percent decrease over losses of $(0.31) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment